Adam Joseph Rosenberg - Net Worth and Insider Trading

Adam Joseph Rosenberg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Adam Joseph Rosenberg owns 1 companies in total, including Climb Bio Inc (CLYM) .

Click here to see the complete history of Adam Joseph Rosenberg’s form 4 insider trades.

Insider Ownership Summary of Adam Joseph Rosenberg

Ticker	Comapny	Transaction Date	Type of Owner
CLYM	Climb Bio Inc	2021-08-09	director

Adam Joseph Rosenberg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Adam Joseph Rosenberg Ownership Network

Ownership Network List of Adam Joseph Rosenberg

No Data

Ownership Network Relation of Adam Joseph Rosenberg

Adam Joseph Rosenberg Owned Company Details

What does Climb Bio Inc do?

Who are the key executives at Climb Bio Inc?

Adam Joseph Rosenberg is the director of Climb Bio Inc. Other key executives at Climb Bio Inc include Chief Accounting Officer Emily Pimblett , Chief Scientific Officer Valerie Morisset , and director & 10 percent owner Ra Capital Healthcare Fund Lp .

Climb Bio Inc (CLYM) Insider Trades Summary

Over the past 18 months, Adam Joseph Rosenberg made no insider transaction in Climb Bio Inc (CLYM). Other recent insider transactions involving Climb Bio Inc (CLYM) include a net sale of 481,639 shares made by Valerie Morisset , a net sale of 2,436 shares made by Emily Pimblett , and a net purchase of 13,008,546 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 1,191 shares of Climb Bio Inc (CLYM) in total and bought 0 shares, with a net sale of 1,191 shares. During the past 18 months, 484,075 shares of Climb Bio Inc (CLYM) were sold and 13,008,546 shares were bought by its insiders, resulting in a net purchase of 12,524,471 shares.

Climb Bio Inc (CLYM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Climb Bio Inc Insider Transactions

No Available Data

Adam Joseph Rosenberg Mailing Address

Above is the net worth, insider trading, and ownership report for Adam Joseph Rosenberg. You might contact Adam Joseph Rosenberg via mailing address: C/o Eliem Therapeutics, Inc., 23515 Ne Novelty Hill Rd, Ste B221 #125, Redmond Wa 98053.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.